An ultrasound imaging technique that picks up early evidence of peripheral arterial disease (PAD) currently missed in conventional tests has been developed by researchers* at Oregon Health and Science University (OHSU).
GE Healthcare in unveiling LOGIQ E9, a pioneering sonography system that can generate a precise image fusion from CT/MRT and sonographic volume data, the firm reports.
A growing number of Dutch hospital doctors now favour ultrasound (US) over CT scans to detect appendicitis in children. This trend has re-opened the US v. CT debate over which diagnostic method is more effective, cost-effective and safest for a child's longer-term health needs.
The Centre for Medical Imaging Ruhr (zmb ruhr) in Bochum offers the technological infrastructure for the development of therapeutic and diagnostic imaging procedures. The primary focus is on ultrasound — the most commonly used imaging procedure in Germany, delivering the highest volume of examinations.
Siemens Healthcare is showing a very innovative application on the new ACUSON S2000 ultrasound system. “The software packages Virtual Touch tissue imaging and Virtual Touch tissue quantification represent the clinical realisation of a method, previously known as Acoustic Radiation Force Impulse (ARFI) technology”, the firm explains.
A UK collaboration, led by an optical imaging company has produced its first optical coherence tomography (OCT) tissue images at a wavelength of 1 µm. Based on interferometry, OCT works by analysing near-infrared light reflected from a sample and using differences in the reflected intensities to create high-resolution images. Employing 1 µm light - as opposed to the longer wavelength…
In October, the office of the Federal President announced that Professor Haverich, with his Hanover research team, has been nominated for the 'German Future Prize' for the development and successful use of adaptable biological heart valves
A team of researchers from Brazil recently published details of a free-to-air software called CALDose_X which is being billed as a milestone towards the goal of patient-specific dosimetry in X-ray diagnosis.
If, in the early days of mammary sonography, it was revealed to be helpful to render tactual findings in a visible manner (sonic palpation), then now is the time to palpate clinically occult findings in a new manner (Elastoscan*).
This September, Carestream Health revealed the first wireless cassette-size DR Detector. The Carestream DRX-1 system, which incorporates a console and wireless 14x17 inch cassette-size digital radiography (DR) detector, provides a rapid, affordable conversion for users of radiographic film or computed radiography systems, Carestream explains.
Edan Instruments Inc., based in Shenzhen, China, is one of the leading medical equipment manufacturers involved in R&D, manufacturing and marketing.
Siemens Healthcare has opened a new research centre in Cologne, where around 40 employees are developing new diagnostic tests to describe the molecular characteristics of breast cancer cells, to help physicians to select individual therapy.
Last year, orthopaedics and sports medicine specialist Dr Rainer Burgkart (left), who is also a musculoskeletal researcher, selected a new C-Arm for use at the Technical University of Munich (Klinikum rechts der Isar). Recently, we asked him for the reasons behind this choice and his subsequent experience with this device.
High frequency ultrasound (US) techniques continue to improve with better resolution and exquisite B-Mode imaging, particularly with improved compounding techniques seen with the Aplipure product.
It is safe to take anticoagulants before core needle breast biopsies, according to a study performed at the Elizabeth Wende Breast Clinic in Rochester, NY.
Carestream Health's engineers created the first wireless DR detector which is not bigger than a standard cassette and can therefore withstand the challenging environment of a modern x-ray department. The rugged detector, case, and internal components are made to produce DR images of high quality under real-life x-ray department conditions.
Intima media thickness (IMT) is a valuable research tool that can be used as surrogate end points in clinical trails, says Professor Stefan Agewall.
The first robotised tele-ultrasound examination has been performed by participants in the European Mobile And Robotised Tele-echography (MARTE) project, in collaboration with Robosoft, specialist in the development and production of service robot systems.
Last October the Food and Drugs Administration (FDA) added a black box warning on ultrasound (US) contrast agents used in echocardiogram imaging examinations, around 200 reports of serious allergic reactions were received. Problems included cardiac arrest as well as breathing difficulty and seizures; seven of the cases resulted in death.
Although ultrasound imaging is a very powerful imaging modality it is mostly under-used Ultrasound combines several very appealing characteristics. It is among the non-invasive imaging modalities, indeed it is really non-invasive. Similar to MRI, no harm to the patient can be caused by ultrasound.
An emerging discipline of noninvasive cardiac imaging, molecular imaging, has evolved constantly in the last few years and is increasingly being translated from the preclinical to the clinical level. Molecular imaging allows for unique insights into specific disease mechanisms and holds great promise to change the practice of cardiovascular medicine by facilitating early disease detection,…
Philips has added a new platform to its HD ultrasound products - the HD15 - which aims to provide small hospitals, clinics and private practices with advanced image clarity and broad application support for everyday use.
Siemens Healthcare will show its Acuson S2000, the first ultrasound system in the new product series S, at the ESC*. The system platform includes integration of the newest technologies to optimise workflow, e.g. comprehensive software applications such as new software for breast imaging.
St. Jude Medical, Inc. has received European CE Mark approval and US Food and Drug Administration (FDA) clearance for its Epicor LP cardiac ablation system, a second generation technology that uses HIFU (high intensity focused ultrasound) for surgical ablation of cardiac tissue to disrupt abnormal cardiac electrical impulses.
